Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy.
Fujii T, Kogawa T, Wu J, Sahin AA, Liu DD, Chavez-MacGregor M, Giordano SH, Raghavendra A, Murthy RK, Tripathy D, Shen Y, Yamal JM, Ueno NT.
Fujii T, et al. Among authors: liu dd.
Br J Cancer. 2017 Feb 14;116(4):509-514. doi: 10.1038/bjc.2016.444. Epub 2017 Jan 12.
Br J Cancer. 2017.
PMID: 28081544
Free PMC article.